Results 211 to 220 of about 176,817 (345)

CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling

Med Research, EarlyView.
CRISPR technology has progressed from a prokaryotic immune system to a diverse suite of editing platforms, including Cas nucleases, base and prime editors, and RNA‐targeting enzymes. These advances enable precise genomic and epigenomic interventions, high‐throughput functional screening, and immune engineering.
Kailai Li, Peixin Huang, Yue Qian, Anqi Lin, Jingjun He, Junyi Shen, Li Chen, Kai Miao, Jian Zhang   +8 more
wiley   +1 more source

Targeting androgen receptor signaling to enhance cancer immunotherapy. [PDF]

Trends Pharmacol Sci
Bader DA, Chakraborty B, McDonnell DP, Hirschey MD.   +3 more
europepmc   +1 more source

CT-Based Quantification of Prostate Volume Change After LHRH-Agonist Androgen Deprivation: A Prospective, Three-Reader Study for Radiotherapy Planning [PDF]

N. Feltes, M. Galdeano Rubio, Jesús Muñoz-Rodríguez, A. Palau Domínguez, Josep Maria Sole Monne, Meritxell Pérez Márquez, S. Pozo, Inma Díaz-Álvarez, Felipe Couñago, Saturio Paredes-Rubio   +9 more
openalex   +1 more source

Incidence and Mortality Risks of Gastrointestinal Cancers During Working‐Age Period: Trends and Disparities in 204 Countries and Territories (1990–2021)

Med Research, EarlyView.
This comprehensive analysis of gastrointestinal (GI) cancer risk reveals that globally, one in 46 people will develop and one in 73 will die from GI cancers during working age (15–64 years), with 2021 incidence and mortality risks of 2.19% and 1.37%, respectively. Key findings demonstrate striking gender disparities, with males facing nearly double the
Yiming Song, Zhongge Ji, Xunbing Zhang, Qian Liang, Zeyu Li, Xiaojie Huang, Jinnan Chen, Yujie Zhou, Xinyuan Wang, Zhao Li, Liuyi Yang, Yixin Qian, Xiaolu Lin, Qingwei Zhang, Xiaobo Li   +14 more
wiley   +1 more source

Selective androgen receptor modulators: a critical appraisal. [PDF]

Front Endocrinol (Lausanne)
Bond P, Smit DL, Verdegaal T, de Ronde W.   +3 more
europepmc   +1 more source

TACC2 Is an Androgen-Responsive Cell Cycle Regulator Promoting Androgen-Mediated and Castration-Resistant Growth of Prostate Cancer

, 2012
Ken‐ichi Takayama, Kuniko Horie‐Inoue, Takashi Suzuki, Tomohiko Urano, Kazuhiro Ikeda, Tetsuya Fujimura, Satoru Takahashi, Yukio Homma, Yasuyoshi Ouchi, Satoshi Inoue   +9 more
openalex   +1 more source

Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancer [PDF]

, 2017
Timothy C. Thompson, Likun Li
openalex   +1 more source

androgen

Citation: 'androgen' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.10384 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms. Requests for commercial usage
openaire   +1 more source

Advances and Prospects of Stereotactic Radiosurgery and Stereotactic Ablative Body Radiotherapy: Evolving Paradigms in Precision Oncology

Med Research, EarlyView.
The graphical abstract outlines the progressive development and impact of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). Technological Evolution illustrates the transition from brachytherapy with single‐dose, LDR/HDR schedules to fractionated radiotherapy, three‐dimensional conformal radiotherapy (3DCRT) and Gamma Knife ...
Jing Zhang, Wenhao Xu, Weiqing Lu, Yingxuan Lin, Luoxi He, Zonglin Lv, Yiliyaer Nuerrula, Zouting, Zhen Zhang, Hailiang Zhang, Xuejun Ma   +10 more
wiley   +1 more source

Improved androgen specificity of AR-EcoScreen by CRISPR based glucocorticoid receptor knockout

, 2017
Nick Zwart, Dave Andringa, Willem-Jan de Leeuw, Hiroyuki Kojima, Mitsuru Iida, Corine J. Houtman, J. de Boer, Jeroen Kool, M.H. Lamoree, Timo Hamers   +9 more
openalex   +1 more source